Brief: Hofseth Cash And Cash Equivalents Rise By NOK 6.2 Mln In Q4

Hofseth Biocare ASA

09/02/2024 07:21

Feb 9 (Reuters) - Hofseth Biocare ASA  HBC.OL :
    * GROSS MARGIN IN Q4 IS NEGATIVELY IMPACTED BY AN
EXTRAORDINARY
WRITE-DOWN OF 15 MILLION NOK OF OUR EXCESS CALCIUM INVENTORY
    * CASH AND CASH EQUIVALENTS INCREASED BY NOK 6.2M DURING
QUARTER,
LEAVING TOTAL HOLDING AT NOK 23.9M AT END OF YEAR

Source text for Eikon:  ID:nGNE18RywL 
Further company coverage:  HBC.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))